American Herbal Products Association (AHPA) > News > Latest News

AHPA corrects JAMA research letter that misidentifies illegal drug products as dietary supplements

The American Herbal Products Association (AHPA) responded to a research letter, "Presence of Banned Drugs in Dietary Supplements Following FDA Recalls," published October 21 in the Journal of the American Medical Association (JAMA), to correct the letter for falsely identifying illegal, adulterated drugs as dietary supplements.

Industry Coalition Reminds Consumers, Retailers Dietary Supplements Cannot Claim to Cure, Prevent Ebola Virus

WASHINGTON, D.C. - The dietary supplement industry is aware of public concern regarding the Ebola virus ("Ebola virus disease") and of the desire of the public to protect itself against this virus. The trade associations of the dietary supplement industry support the responsible sale and use of health-promoting vitamins, minerals, herbs and other dietary supplements. We are unaware of any scientific data supporting the use of dietary supplements to prevent Ebola virus infection or treat Ebola virus disease. Furthermore, federal law does not allow dietary supplements to claim to treat any diseases, including Ebola virus disease.

October 2014 AHPA Report

The importance of reliable product chemistry data: a case study by Dallas Wait, Ph.D., Gradient and much more...

AHPA proposal for more useful Prop 65 warning gains traction among regulators

OEHHA to consider AHPA's informative, consumer friendly label warning

In a breakthrough meeting with AHPA president Michael McGuffin on Sept. 25, top officials of the California Office of Environmental Health Hazard Assessment (OEHHA) recognized the value of AHPA's innovative proposal to allow more informative warnings for California's Proposition 65-listed reproductive toxins to replace the inflammatory and alarming language currently required. Based on this understanding, OEHHA requested AHPA to present specific recommendations on how to change the current regulations.

AHPA President provides supplement regulation compliance strategies at Effective Compliance Seminar

AHPA President Michael McGuffin on Tuesday provided an overview of supplement regulations and compliance strategies at the Best Practices in QC, GMP for Dietary Supplements and Nutraceuticals Effective Compliance Seminar in Salt Lake City.

AHPA President speaks at annual Health Concerns Symposium

AHPA President Michael McGuffin on Sunday provided an update of issues impacting the herbal products industry at the annual Health Concerns Symposium, an educational event for practitioners, students, and partners in the holistic, herbal and alternative medicine community held in San Francisco. 

Cannabis oversight recommendations for regulators

Oversight framework promotes best practices for cannabis production and distribution from seed to consumption

The American Herbal Products Association (AHPA) has published recommendations for regulators to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species.

September 2014 AHPA Report

Think twice before you “like” by AHPA Staff, Botanical Congress to focus on herbal ingredient Identification and much more...

AHPA membership increases more than 12 percent with 45 new members in 2014

AHPA welcomes 17 new members this quarter

The American Herbal Products Association (AHPA), the global trade association and voice of the herbal products industry, has announced it has added 17 new members during the third quarter, for a total of 45 new member companies joining in 2014 -- a 12 percent increase in membership this year.

AHPA generally supports FDA's proposed Rule, but recommends some changes

The American Herbal Products Association (AHPA) expressed general support and provided recommended changes for the Food and Drug Administration's (FDA's) proposed Rule, "Food Labeling: Revision of the Nutrition and Supplement Facts Labels."
RSS
First 19202122232425262728 Last

2018 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.